TR-0304

N/A

Report date: 2025/02/14 11:13:22

Base Information

Drug NameTR-0304

Drug Alias NameTR0304TR-0304

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Programmed death-ligand 1Anti-Lymphocyte activation gene 3 protein

TargetsProgrammed death-ligand 1Lymphocyte activation gene 3 protein

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity of Naples Federico II

China Registration ClassN/A

Develop Information

Active CompaniesUniversity of Naples Federico II

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A